CDKN1B and liver dysplastic nodule: (47) revealed the decrease of CDKN1B mRNA expression in the glomeruli of DN patients in the Nephroseq data set and confirmed that the expression level of CDKN1B mRNA in podocytes decreases gradually as glucose concentration rises, which is consistent with our findings.